These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29449541)

  • 1. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
    Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
    Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.
    Han B; Meng X; Chen H; Chen L; Liu X; Wang H; Liu D; Gao F; Lin L; Ming J; Sun B; Yin S; Wang R; Wu P; Cai J; Jiang C
    Aging (Albany NY); 2017 Aug; 9(8):1885-1897. PubMed ID: 28858851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
    Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
    Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2.
    Fan Z; He J; Fu T; Zhang W; Yang G; Qu X; Liu R; Lv L; Wang J
    Biochem Biophys Res Commun; 2019 Jun; 513(4):834-840. PubMed ID: 31003765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a.
    Xin X; Wu M; Meng Q; Wang C; Lu Y; Yang Y; Li X; Zheng Q; Pu H; Gui X; Li T; Li J; Jia S; Lu D
    Mol Cancer; 2018 Jun; 17(1):94. PubMed ID: 29895332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis.
    Zhu Y; Jin L; Shi R; Li J; Wang Y; Zhang L; Liang CZ; Narayana VK; De Souza DP; Thorne RF; Zhang LR; Zhang XD; Wu M
    Mol Cell; 2022 Feb; 82(3):542-554.e6. PubMed ID: 35081364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA MEG3 promotes autophagy and apoptosis of nasopharyngeal carcinoma cells via PTEN up-regulation by binding to microRNA-21.
    Lin L; Liu X; Lv B
    J Cell Mol Med; 2021 Jan; 25(1):61-72. PubMed ID: 33332708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKM2 promotes glioma progression by mediating CTNNB1 expression.
    Ma C; Feng Y; Zhong K; Wei J
    Neurol Res; 2024 Jul; 46(7):583-592. PubMed ID: 38797679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
    Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
    Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis.
    Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy.
    Wang C; Jiang X; Li X; Song S; Meng Q; Wang L; Lu Y; Xin X; Pu H; Gui X; Li T; Lu D
    Stem Cell Res Ther; 2020 Jan; 11(1):8. PubMed ID: 31900225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
    Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
    Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
    [No Abstract]   [Full Text] [Related]  

  • 16. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway.
    Li P; Gao Y; Li J; Zhou Y; Yuan J; Guan H; Yao P
    J Cell Biochem; 2018 Sep; 119(9):7498-7505. PubMed ID: 29781534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.
    Wen YY; Liu WT; Sun HR; Ge X; Shi ZM; Wang M; Li W; Zhang JY; Liu LZ; Jiang BH
    Sci Rep; 2017 Nov; 7(1):15897. PubMed ID: 29162853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEG3 interacted with miR-494 to repress bladder cancer progression through targeting PTEN.
    Shan G; Tang T; Xia Y; Qian HJ
    J Cell Physiol; 2020 Feb; 235(2):1120-1128. PubMed ID: 31294463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.